67132-01-8

Upstream product

• 120-47-8 Ethyl 4-hydroxybenzoate 
• 64994-49-6 1-bromo-2-propoxyethane 
• 42149-74-6 2-chloroethyl propyl ether 
• 99-96-7 4-hydroxy-benzoic acid 
• 2807-30-9 2-propoxyethanol 
• 52497-47-9 propoxyethyl 4-methylbenzensulfonate 

Downstream Products

• 359586-02-0 allyl {2-methyl-1-[4-(2-propoxyethoxy)benzoyl]-1H-indol-4-yl}acetate 

Relevant academic research and scientific papers

Synthesis and determination of physicochemical properties of new 3-(4-arylpiperazin-1-yl)-2-hydroxypropyl 4-alkoxyethoxybenzoates

Nine new dihydrochloride salts of 3-(4-arylpiperazin-1-yl)-2-hydroxypropyl 4-alkoxyethoxybenzoates were designed and synthesized. The physicochemical properties such as lipophilicity index (log kw) and dissociation constant (pKa) wer

Indole derivatives, process for preparation of the same and use thereof

Indole derivatives represented by formula (I): (wherein all symbols are described in the description), a process for the preparation of the same and a DP receptor antagonist comprising it as an active ingredient. Since the compounds of formula (I) binds to and are antagonistic to a DP receptor, they are useful in for the prevention and/or treatment of diseases, for example, allergic diseases (allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma, food allergy, etc., systemic mastocytosis; disorders due to systemic mastocyte activation, anaphylactic shock, bronchoconstriction, urticaria, eczema, etc.), diseases accompanied with itching (atopic dermatitis, urticaria, etc.), secondary diseases caused by behaviors (scratching behaviors, beating, etc.) (cataract, retinal detachment, inflammation, infection, sleep disorder, etc.), inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, cerebrovascular disorder, pleuritis complicated by rheumatoid arthritis, ulcerative colitis, and the like.